Contact: Tom Still or Liz Schrum at 608-695-7557
To learn more: http://www.wisconsintechnologycouncil.com
MADISON – Nineteen early stage companies from Wisconsin will be among 47 presenting companies at the MidAmerica Healthcare Venture Forum, to be held Nov. 11-12 at Madison’s Monona Terrace Community and Convention Center.
The companies, which represent a broad cross-section of Wisconsin’s biotechnology, medical device, drug discovery and diagnostic firms, will make short presentations to investors from 15 states who will attend the conference.
Of the 47 companies selected to present, 19 are from Wisconsin, eight are from Ohio, six from Michigan, three each from Minnesota and Kentucky, two each from Iowa, Illinois and Indiana, and one each from Kansas and Missouri.
Selection of the companies was made by a committee of the MidAmerica Health Investors Network. The MidAmerica Healthcare Investors Network, which produces the forum in cooperation with International Business Forum in New York, is an association of 48 venture capital firms from 14 states. Those firms collectively have about $2 billion in assets under management.
“The strong showing by Wisconsin companies is evidence of the depth and breadth of the state’s early stage economy. We’re pleased that MHIN selected a diverse selection of Wisconsin companies for a spot on their prestigious stage,” said Tom Still, president of the Wisconsin Technology Council. The Tech Council and Forward Wisconsin are local hosts for the conference.
Wisconsin companies selected to present are: Addiction Therapeutix, Inc.; BioSystem Development, LLC; CellCura, Inc.; Cellectar, Inc.; Cellular Dynamics International, Inc.; Compact Particle Acceleration Corp.; Echometrix; EraGen Biosciences, Inc.; Flex Biomedical; FluGen, Inc.; Gentel Biosciences, Inc.; GWC Technologies, Inc.; Mithridion, Inc.; Nerites Corporation; NeuWave Medical; Phoenix Nuclear Labs; Quintessence Biosciences, Inc.; Rapid Diagnostek, Inc.; and Ratio, Inc.
MHIN focuses on life sciences investment opportunities in the region. Those opportunities include biotechnology, medical devices, bioinformatics, healthcare information technology and healthcare services. Key MHIN members in Wisconsin include Venture Investors LLC and Baird Venture Partners. The Wisconsin Technology Council and Forward Wisconsin have taken the lead in working with forum organizers.
The forum unites venture capitalists, private equity firms, corporate investors and investment bankers from around the region – and nationally – to explore investment opportunities. Past forums have attracted C-level executives from biotechnology, medical device and industrial biotechnology companies; business development executives; tech transfer officers and companies.
This year’s forum will begin on the evening of Nov. 10 with a joint reception during the Wisconsin Early Stage Symposium at Madison’s Monona Terrace Convention Center. The Early Stage Symposium – which will also feature presentations by Wisconsin tech-based companies across a number of sectors – will be held Nov. 10-11.
For sponsorship or registration information for both events, contact Liz Schrum of the Wisconsin Technology Council at 608-442-7557, ext. 27, or [email protected]